Kura Oncology amended executive employment agreements for Troy E. Wilson, Brian Powl and Kathleen Ford to modify severance provisions.
| IndividualTroy E. Wilson, Ph.D., J.D.Brian PowlKathleen Ford | RoleChairman, President and Chief Executive OfficerChief Commercial OfficerChief Operating Officer | Type of ChangeAmendment to employment agreementAmendment to employment agreementAmendment to employment agreement | Effective DateJuly 24, 2026July 27, 2026July 27, 2026 | ReasonTo modify certain severance provisionsTo modify certain severance provisionsTo modify certain severance provisions | Replacement InfoNot disclosedNot disclosedNot disclosed | Background DetailsExecutive holds CEO, President and Chairman roles (as stated)Executive holds Chief Commercial Officer role (as stated)Executive holds Chief Operating Officer role (as stated) | Board/Committee Role ChangesNot disclosedNot disclosedNot disclosed |
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.